1990 Fiscal Year Final Research Report Summary
Participation of Arachiclonic Acid Lipoxygenase Products in the Pathogenesis of Cerebral Vasospasm After SAH.
| Project/Area Number |
01570813
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Cerebral neurosurgery
|
|---|
| Research Institution | Tottori University |
|---|
Principal Investigator |
WATANABE Takashi Tottori University School of Medicine Assoc. Prof., 医学部, 助教授 (00175100)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
ANNO Yuichi Tottori University School of Medicine Res. Assoc., 医学部, 助手 (10168049)
|
|---|
| Project Period (FY) |
1989 – 1990
|
| Keywords | Subarachnoid Hemorrhage / Cerebral Vasospasm / Arachidonic Acid / Lipoxygenase / 12-HPETE / 12-HETE |
|---|
| Research Abstract |
In our previously studies, cerebral vasospasm was experimentally produced by the canine two-hemorrhage model. 12-Lipoxygenase metabolites of the arachidonic acid, 12-hydroxyeicosatetraenoic acid (HETE), was mainly detected as a amount of about 2 nmol/ g wet weight in the subarachnoid clot by reversed-phase High-Performance Liquid chromatography (HPLC). This arachidonate 12-lipoxygenase metabolite was presumably formed rightly after blood clotting in the subarachnoid space by 12-lipoxygenase originated from platelets and leukocytes. We also investigated 5-lipoxygenase activity of basilar arteries with vasospasm in the same model. Twenty to one hundred fold of 5-HETE was produced in the vessels with vasospasm, compared with untreated ones. Moreover, leukotriene B_4 and C_4 were detected in the spasm arteries, but not in the control ones. This activation of 5-lipoxygenase pathway in the spasm arteries was due to the intrinsic 5-lipoxygenase of the vessels, which was stimulated by 12-Hydro
… More
peroxyeicosatetraenoic acid (HPETE), the precursor of 12-HETE, since leukocytes (rich sources of 5-lipoxygenase) were rarely found in the microscopic observation. These results led us to carry out the experiment to see whether the cisternal injection of 12-HPETE could cause the delayed cerebral vasospasm or not.
12-HPETE and 12-HETE were synthesized from arachidonic acid by partially purified porcine leukocyte 12-lipoxygenase, and purified using straight-phase HPLC. The injection of 12-HPETE (0.5 mg) into the canine cisterna magna caused a delayed onset of cerebral vasospasm that lasted long. 12-HPETE in CSF was rapidly reduced to 12-HETE, which was also disappeared within 6 hours after cisternal injection. And then, intrathecal arteries began to contract. This contraction continued for 5 or 6 days. This phenomenon mimicked the cerebral vasospasm as shown in the one-hemorrhage model in our previous experiment. 12-HETE (0.5 mg) injected into CNS had much less potency to induce cerebral vasospasm. We substantiated that 12-HETE was contained in the subarachnoid clot. 12-HPETE is a possible initiator of the delayed cerebral vasospasm. Furthermore, the cisternal injection of 15-HPETE and 13-hydroperoxyoctadecadienoic acid (hydroperoxide of linoleic acid) also successfully caused delayed cerebral vasospasm. Lipid peroxides should be convincing candidates for the initiators of that. Less
|
